Navigation Links
National Cancer Institute Research Identifies Unique Mechanism of Brostallicin's Anti-Tumor Effectiveness
Date:7/20/2009

containing regimens where high glutathione levels are associated with chemotherapy resistance."

About Brostallicin

Brostallicin, a novel synthetic second-generation DNA minor groove binder, has shown potent cancer killing activity, and has demonstrated synergism in combination with standard cytotoxic agents as well as with newer targeted therapies, in preclinical experimental tumor models. Brostallicin binds covalently to DNA within the DNA minor groove, interfering with DNA division and leading to tumor cell death. More than 200 patients have been treated with brostallicin in single-agent and combination studies. Brostallicin had predictable and predominantly hematologic toxicities. Activity was demonstrated in a number of solid tumor types. A phase II study of brostallicin in relapsed/refractory soft tissue sarcoma met its pre-defined activity and safety hurdles and resulted in a first-line phase II study that is currently being conducted by the European Organization for Research and Treatment of Cancer (EORTC).

About Systems Medicine (SM)

In July 2007, CTI acquired Systems Medicine, a privately-held oncology company, in a stock-for-stock merger. SM applies a systems biology approach to drug development, combining pharmacogenomics and bioinformatics with experienced preclinical, clinical, and regulatory expertise to find and exploit a specific cancer's 'context of vulnerability.' Specifically, SM defines the molecular and genetic alterations (context) that cause cancer cells to be particularly sensitive (vulnerable) to a drug or combination of drugs--the "context of vulnerability."

About Cell Therapeutics, Inc.

Headquartered in Seattle, CTI is a biopharmaceutical company committed to developing an integrated portfolio of oncology products aimed at making cancer more treatable. For additional information, please visit

SOURCE Cell Therapeutics, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Vicus Therapeutics to Present at the 234th American Chemical Society National Meeting in Boston, MA
2. National Stem Cell Holding, Inc. Discovers Non-Embryonic Biomaterials that Promote Tissue Repair
3. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
4. Paper in International Journal of Oncology Reports Alfacells ONCONASE(R) Suppresses Intracellular Oxidative Stress
5. Ozarelix Phase 2 Data Presented at 29th Congress of the Societe Internationale dUrologie
6. Anadys Pharmaceuticals Presents Preclinical Results on ANA598, a Non-Nucleoside Inhibitor of the NS5B Polymerase, at the 14th International Symposium on Hepatitis C Virus and Related Viruses
7. Public Forum to Discuss Addiction as a Treatable Disease and Highlight National Alcohol and Drug Addiction Recovery Month
8. K-State Researchers Bringing Expertise to Kansas City Symposium on Disease and National Security
9. International Expert Group Initiates Largest Multi-center Phase III Trial to Evaluate NeuroAid(TM) in Stroke Recovery
10. September is National Pain Awareness Month
11. Virogenomics, Inc. Awarded $2 Million National Institute of Standards and Technology (NIST) Advanced Technology Program Grant to Develop Integrated Diagnostic Biosensors
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... 27, 2015 Research ... addition of the  "North America Mammography Market ... 2019)"  report to their offering. ... is a detailed type of imaging that ... breasts. A mammography exam, called a mammogram, ...
(Date:5/27/2015)... -- Sequenom, Inc. (NASDAQ: SQNM ), a life sciences ... of innovative products and services, today announced that its ... operations in Grand Rapids, Michigan ... , North Carolina.  Sequenom Laboratories, cystic fibrosis carrier screen ... North Carolina laboratory location.  "The ...
(Date:5/27/2015)... YORK , May 27, 2015 PharmaPoint: Type ... 2023 Summary Type 1 diabetes (T1D) is an ... islet, which means that the body can no longer produce ... evolving continuously, as at present, no other treatment can be ... A variety of insulin analogs with different times of action ...
Breaking Medicine Technology:North America Mammography Market - Growth, Trends And Forecasts (2014 - 2019) 2Sequenom Laboratories To Consolidate Michigan And North Carolina Facilities 2Sequenom Laboratories To Consolidate Michigan And North Carolina Facilities 3PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 2PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 3PharmaPoint: Type 1 Diabetes - Global Drug Forecast and Market Analysis to 2023 4
... 2011 /PRNewswire-Asia-FirstCall/ -- China Sky One Medical, Inc. ("China Sky ... leading fully integrated pharmaceutical company producing over-the-counter drugs in the ... the fourth quarter and fiscal year ended December 31, 2010. ... 2010 Highlights Total revenues decreased by ...
... 2011 Optimer Pharmaceuticals, Inc. (Nasdaq: OPTR ... Trademark Office (USPTO) has issued U.S. Patent 7,906,489 which ... treatment with fidaxomicin.  The patent, which is eligible for ... Book, also received a term adjustment of an additional ...
Cached Medicine Technology:China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 2China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 3China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 4China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 5China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 6China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 7China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 8China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 9China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 10China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 11China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 12China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 13China Sky One Medical Announces Fourth Quarter and Fiscal Year 2010 Results 14Optimer Pharmaceuticals Announces Issuance of Key Patent Covering Fidaxomicin Methods of Use as a Treatment of Clostridium difficile infection 2
(Date:5/27/2015)... 27, 2015 “We are honored to ... executive vice president and vice president of clinical affairs ... possible allows us to provide comprehensive care to more ... , SSCHC provides clinical care and behavioral health services ... in 2014, many of whom took advantage of the ...
(Date:5/27/2015)... 2015 Continuing its commitment to finding ... in the community, SmartPractice® donated $25,000 to ... Lincoln). SmartPractice Vice President of Human Resources Meg Mosher ... $25,000 check to Paulla Miller, Sherry Gage, Dr. Linda ... Research Center on April 30. The center is located ...
(Date:5/27/2015)... 2015 In today's healthcare landscape, where ... can be challenging for doctors and hospitals to keep ... , Austin-based HealthTronics, Inc. is offering ... medical therapies for clinically sophisticated applications. The company has ... of Laser Ventures, Inc ., a mobile laser ...
(Date:5/27/2015)... The new http://www.carsonenergy.com includes extensive ... consider oil and gas investing, the substantial tax benefits ... industry news, IRA investing, definitions and acronyms, info-graphics and ... and experience is now in one central location, for ... to access 24 hours a day, 7 days a ...
(Date:5/27/2015)... 27, 2015 In support of a ... issue of the Journal of American Geriatrics Society about ... obesity, Bedford Commons OB-GYN P.A . is reiterating ... sweetener-flavored beverages. , To examine the relationship between ... San Antonio Longitudinal Study of Aging (SALSA) tracked the ...
Breaking Medicine News(10 mins):Health News:Sixteenth Street Community Health Centers To Expand Primary Care and Behavioral Health Services Through $1 Million Grant From Aurora's Better Together Fund 2Health News:SmartPractice Donates $25,000 to HonorHealth Breast Health and Research Center 2Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 2Health News:HealthTronics Invests in Additional Mobile Medical Technologies As Cost Efficient Solution for Hospitals, Doctors 3Health News:Carson Energy Launches Next Generation Investor Website 2Health News:Recent Study About the Link Between Diet Sodas and Abdominal Fat Reinforces Bedford Commons OB-GYN's Recommendation to Drink Plenty of Water 2
... Solos Endoscopy, Inc. (OTCPK:,SNDY) is pleased to announce ... for the period ending June 30, 2008. Revenues,generated through ... $151,347.53 for the comparable period in 2007. The Company,saw ... $13,242 compared with just,over $8,000 at the end of ...
... there are no safe substitutes for authentic,FDA approved ... unbranded,unapproved and counterfeit cosmetic injectables are a threat ... Coalition for Injectable Safety. "The,growing acceptance of cosmetic ... comes with consumer cautions," says Coalition,leader, plastic surgeon ...
... October 7, 2008 Extreme heat events (EHE), or ... human mortality in the United States, responsible for more ... combined. These events, and other climate-related changes in the ... in the November issue of the American Journal ...
... Hong Kong Celebrates a Wealth of Innovative Products, ... world leader in,research and development, announces today that it ... October 2008 at Gordon Wu Hall, B P,International House ... Founded in 1902 in Minnesota, United States, 3M has ...
... 8 A recent study comparing eight,leading ... prescription packages that could impact patient safety ... are contained in them., Pharmacy Healthcare ... Pittsburgh, PA, conducted a study to analyze ...
... Orthopedics, Inc. today,announced the first human use of ... The landmark case was performed by Dr. Karin,Buttner-Janz, ... the Vivantes,Clinic in Berlin, Germany, and involved a ... developed symptomatic facet joint,degeneration. "Generally in this situation ...
Cached Medicine News:Health News:Solos Endoscopy, Inc. Posts First Six Months Financials of 2008 on Pinksheets.com 2Health News:Illegal Botox Scammers a Public Threat 2Health News:Illegal Botox Scammers a Public Threat 3Health News:Illegal Botox Scammers a Public Threat 4Health News:Illegal Botox Scammers a Public Threat 5Health News:Climate change will affect public health -- a call to action 2Health News:Climate change will affect public health -- a call to action 3Health News:3M Innovation Day 2Health News:3M Innovation Day 3Health News:Test Results from Pharmacy Healthcare Solutions Show not all Prescription Packaging is Created Equal 2Health News:Archus Orthopedics Performs First Facet Replacement Procedure With an Artificial Disc 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: